CMV - gastroenteritis/colitis

• A
• B
• C
• D
• E
• F
• G
• H
• I
• J
• K
• L
• M
• N
• O
• P
• Q
• R
• S
• T
• U
• V
• W
• X
• Y
• Z

Gastrointestinal anatomy

Stomach and stomach lining

CMV gastroenteritis or colitis is an inflammation of the stomach or intestine caused by infection with cytomegalovirus (CMV).

Colitis - cytomegalovirus; Gastroenteritis - cytomegalovirus; Esophagitis - cytomegalovirus; Gastrointestinal CMV disease

Cytomegalovirus (CMV) is present worldwide, and infections are very common. In the third world, CMV infection occurs at or near the time of birth. In more developed countries, infection usually occurs during infancy, but can occur in childhood or adolescence.

CMV is transmitted in situations of close interpersonal contact. The virus has been isolated in nearly all organs and body fluids in the human body. By adulthood, up to 80% of the population has anti-CMV antibodies, which indicates prior infection.

CMV infection in people with healthy immune systems usually produces no symptoms. However, a flu-like syndrome can occur. In rare instances, more severe CMV infection, involving the GI tract, has been reported in people with normal immunity.

Patients with CMV colitis show symptoms such as fever, bloody diarrhea, and abdominal pain. When CMV colitis occurs in patients with normal immune systems, they typically have other serious medical problems, such as severe trauma, renal failure, or infection.

A special category of patients -- those who have inflammatory bowel diseases such as Crohn's disease and ulcerative colitis -- can suffer from gastrointestinal CMV infections. A small number of patients who have undergone colectomy for ulcerative colitis have been found to have symptomatic CMV infections in their remaining intestine.

CMV infections of the GI tract that cause symptoms are more common in those with impaired immune systems, and in these patients serious infections can occur.

People at risk include those with AIDS, recipients of organ transplants (overall incidence between 2-16%) or bone marrow transplants (overall incidence between 32-52%), and people receiving chemotherapy or other immunosuppressive treatments. Immunocompromised people who develop CMV gastroenteritis and colitis can have severe illness.